Ehrlichia Notch SLiM-activated oncoprotein inhibition of apoptosis
埃里希氏菌Notch SLiM激活的癌蛋白抑制细胞凋亡
基本信息
- 批准号:10513824
- 负责人:
- 金额:$ 40万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-11-01 至 2026-10-31
- 项目状态:未结题
- 来源:
- 关键词:ApoptosisApoptosis InhibitorApoptoticBCL-2 ProteinBIR DomainBacteriaBindingCASP3 geneCaspaseCell CommunicationCell SurvivalCell physiologyCellsDevelopmentDiseaseDown-RegulationEhrlichiaEhrlichia chaffeensisEhrlichiosisEtiologyEukaryotic CellEventFBXW7 geneGenetic TranscriptionGenomeGoalsHost DefenseHost Defense MechanismHumanImmuneImmune EvasionInfectionInflammationInhibition of ApoptosisInvestigationKnowledgeLaboratoriesLifeLigandsLinkMCL1 geneMediatingMembrane ProteinsMitochondriaMolecularMolecular MimicryMononuclearNotch Signaling PathwayOncoproteinsPathway interactionsPhagocytesPlayPositioning AttributePost-Translational Protein ProcessingProtein InhibitionProteinsReceptor SignalingRegulationResearchRoleScienceSignal PathwaySignal TransductionSurfaceSystemTLR2 geneTandem Repeat SequencesToll-like receptorsin vivomimeticsmimicrynew therapeutic targetnotch proteinnovel therapeutic interventionpathogenpreventprogramsprotein protein interactionreceptorreceptor bindingreceptor expressiontick-borneubiquitin ligase
项目摘要
ABSTRACT
Ehrlichia chaffeensis (E. ch.) is a gram-negative, obligately intracellular bacterium and the etiologic agent of
human monocytotropic ehrlichiosis (HME), an emerging, life-threatening, tick-borne zoonosis. E. ch.
preferentially infects mononuclear phagocytes and survives intracellularly by subverting innate immune defenses
mediated in part by tandem repeat protein (TRP) effectors. Within the last decade, our laboratory has identified
a multitude of molecular ehrlichial TRP-host interactions, many that are new to science, illuminating the breath
and complexity of pathogen-host interaction dynamics that occur during infection. We have shown that E. ch. is
dependent on activation of conserved eukaryotic signaling pathways including Notch and Wnt for infection.
However, understanding the molecular basis of Notch activation events, whereby E. ch. repurposes Notch
signaling for infection remains a major gap in our knowledge. Thus, the purpose of this investigation is to define
the molecular and cellular mechanisms E. ch. has evolved to repurpose Notch signaling for infection. We propose
that E. ch. TRP120 has distinct eukaryotic protein interaction modules known as short linear motifs (SLiMs) that
mimic Notch ligand function and directly engage cognate receptors to exploit Notch signaling for infection. This
investigation will address our limited understanding of the functionally diverse roles of protein interaction modules
in the continuum of host-pathogen interactions and cellular reprogramming. The long-term goal of this research
is to define the molecular basis of Ehrlichia host cell mimicry, and the mechanisms involved in infection and
immune evasion. The objective of this proposal is to determine the molecular interactions involved and functional
mechanisms whereby E. ch. TRP120 Notch ligand mimicry establishes and promotes infection by inhibiting host
cell apoptosis. We hypothesize that E. ch. TRP120 has a Notch SLiM mimetic that activates Notch signaling to
upregulate anti-apoptotic regulators (MCL1 and NICD), thereby inhibiting mitochondrial apoptotic signaling and
caspase activation. Aim 1 will define the E. ch. TRP120 Notch SLiM mimetic and investigate receptor binding
and signaling; Aim 2 will examine E. ch. TRP120 Notch-upregulated MCL1 inhibition of mitochondrial apoptosis;
and Aim 3 will investigate the role of E. ch. Notch stabilization of XIAP and inhibition of caspase activation. This
investigation will extend our knowledge of the molecular interactions by which E. ch. TRP120 surface protein
exploits Notch signaling to inhibit apoptosis and promote host cell survival and infection. The significance of this
research is defining the mechanistic strategies whereby intracellular pathogens with small genomes and a limited
number of effector proteins, have evolved host mimicry modules to repurpose host cell signaling to manipulate
downstream host defense mechanisms for infection. A molecular understanding of E. ch. pathobiology will also
facilitate development of novel therapeutic approaches for Ehrlichia spp. and intracellular pathogens that utilize
SLiM mimicry or exploit conserved cellular pathways for infection and immune evasion.
摘要
查菲埃立克体(Ehrlichia chaffeensis); ch.)是一种革兰氏阴性、专性胞内细菌,
人类嗜单核细胞埃立克体病(HME),一种新出现的、危及生命的、蜱媒人畜共患病。E. ch.
优先感染单核吞噬细胞,并通过破坏先天性免疫防御在细胞内存活
部分由串联重复蛋白(TRP)效应子介导。在过去的十年里,我们的实验室已经确定了
大量的分子Ehrlichial TRP-宿主相互作用,许多是新的科学,照亮呼吸
以及感染期间发生的病原体-宿主相互作用动力学的复杂性。我们证明了E. ch.是
依赖于包括Notch和Wnt在内的保守的真核细胞信号传导途径的激活来进行感染。
然而,理解Notch激活事件的分子基础,即E. ch. repurposes Notch
感染信号仍然是我们知识中的一个主要空白。因此,本次调查的目的是确定
分子和细胞机制E.已经进化到重新利用Notch信号来感染。我们提出
大肠ch.TRP120具有不同的真核蛋白相互作用模块,称为短线性基序(SLiM),
模拟Notch配体功能并直接接合同源受体以利用Notch信号传导进行感染。这
研究将解决我们对蛋白质相互作用模块的功能多样性作用的有限理解
在宿主-病原体相互作用和细胞重编程的连续体中。本研究的长期目标
是确定埃里希体宿主细胞拟态的分子基础,以及感染和
免疫逃避本提案的目的是确定所涉及的分子相互作用和功能
E. ch.TRP120 Notch配体模拟通过抑制宿主
细胞凋亡我们假设E. ch.TRP120具有激活Notch信号传导的Notch SLiM模拟物,
上调抗凋亡调节因子(MCL 1和NICD),从而抑制线粒体凋亡信号传导,
半胱天冬酶激活。目标1将定义E。ch.TRP120 Notch SLiM模拟物并研究受体结合
和信号;目标2将检查E。ch.TRP120 Notch上调的MCL 1对线粒体凋亡的抑制;
Aim 3将探讨E. ch. XIAP的Notch稳定化和半胱天冬酶活化的抑制。这
研究将扩展我们对E. ch.TRP120表面蛋白
利用Notch信号来抑制细胞凋亡并促进宿主细胞存活和感染。其意义
研究正在确定机制策略,从而使具有小基因组和有限的细胞内病原体
许多效应蛋白,已经进化出宿主模拟模块,以重新利用宿主细胞信号传导来操纵
下游宿主感染防御机制。对E.病理生物学也将
促进埃立克体属的新型治疗方法的开发。和细胞内的病原体
SLiM模拟或利用保守的细胞途径进行感染和免疫逃避。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JERE W MCBRIDE其他文献
JERE W MCBRIDE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JERE W MCBRIDE', 18)}}的其他基金
Ehrlichia Notch SLiM-activated oncoprotein inhibition of apoptosis
埃里希氏菌Notch SLiM激活的癌蛋白抑制细胞凋亡
- 批准号:
10365541 - 财政年份:2021
- 资助金额:
$ 40万 - 项目类别:
Molecular basis of Wnt activation by Ehrlichia Wnt ligand mimics
埃里希体Wnt配体模拟物激活Wnt的分子基础
- 批准号:
10117073 - 财政年份:2020
- 资助金额:
$ 40万 - 项目类别:
Ehrlichia TRP120 HECT E3 ubiquitin ligase modulation of host cell pathways
埃里希体 TRP120 HECT E3 泛素连接酶对宿主细胞途径的调节
- 批准号:
10248423 - 财政年份:2020
- 资助金额:
$ 40万 - 项目类别:
Ehrlichia TRP120 HECT E3 ubiquitin ligase modulation of host cell pathways
埃里希体 TRP120 HECT E3 泛素连接酶对宿主细胞途径的调节
- 批准号:
9975529 - 财政年份:2020
- 资助金额:
$ 40万 - 项目类别:
Notch signaling and functional relevance during Ehrlichia chaffeensis infection
恰菲埃里希体感染期间的Notch信号传导和功能相关性
- 批准号:
9408616 - 财政年份:2017
- 资助金额:
$ 40万 - 项目类别:
Notch signaling and functional relevance during Ehrlichia chaffeensis infection
恰菲埃里希体感染期间的Notch信号传导和功能相关性
- 批准号:
9316270 - 财政年份:2017
- 资助金额:
$ 40万 - 项目类别:
Rickettsiales: Disease Models, Immunity and Vaccine Development
立克次体:疾病模型、免疫和疫苗开发
- 批准号:
8911515 - 财政年份:2015
- 资助金额:
$ 40万 - 项目类别:
Ehrlichia T1S Effector Regulation of Host Gene Transcription
埃里希体 T1S 宿主基因转录的效应调节
- 批准号:
8824870 - 财政年份:2014
- 资助金额:
$ 40万 - 项目类别:
Ehrlichia modulation of polycomb group-dependent epigenetic regulation
埃里希体对多梳群依赖的表观遗传调控的调节
- 批准号:
8809777 - 财政年份:2014
- 资助金额:
$ 40万 - 项目类别:
相似海外基金
Parameter-kinetics of apoptosis inhibitor of macrophage (AIM) in contrast-induced nephropathy
对比剂肾病中巨噬细胞凋亡抑制剂(AIM)的参数动力学
- 批准号:
21K15853 - 财政年份:2021
- 资助金额:
$ 40万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Epidemiological study of association between serum level of apoptosis inhibitor of macrophage (AIM) and incidence of metabolic syndrome or abnormal glucose metabolism
血清巨噬细胞凋亡抑制剂(AIM)水平与代谢综合征或糖代谢异常发生率相关性的流行病学研究
- 批准号:
15K19229 - 财政年份:2015
- 资助金额:
$ 40万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.
评估新型细胞凋亡抑制剂 TRAILshort 在维持 HIV 持久性方面的作用。
- 批准号:
8990167 - 财政年份:2015
- 资助金额:
$ 40万 - 项目类别:
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.
评估新型细胞凋亡抑制剂 TRAILshort 在维持 HIV 持久性方面的作用。
- 批准号:
9272805 - 财政年份:2015
- 资助金额:
$ 40万 - 项目类别:
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.
评估新型细胞凋亡抑制剂 TRAILshort 在维持 HIV 持久性方面的作用。
- 批准号:
9089882 - 财政年份:2015
- 资助金额:
$ 40万 - 项目类别:
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence
评估新型细胞凋亡抑制剂 TRAILshort 在维持 HIV 持续存在方面的作用
- 批准号:
10427482 - 财政年份:2015
- 资助金额:
$ 40万 - 项目类别:
Role of apoptosis inhibitor of macrophage (AIM) in the pathogenesis of intractable lung diseases
巨噬细胞凋亡抑制剂(AIM)在难治性肺部疾病发病机制中的作用
- 批准号:
25670398 - 财政年份:2013
- 资助金额:
$ 40万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Rescue of potential oocytes in livestock ovaries by artificial control of apoptosis inhibitor
通过人工控制凋亡抑制剂拯救家畜卵巢中的潜在卵母细胞
- 批准号:
24658231 - 财政年份:2012
- 资助金额:
$ 40万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Relationship of human apoptosis inhibitor NAIP1 between natural resistance against Legionellainfection
人凋亡抑制剂NAIP1与军团菌感染自然抵抗力的关系
- 批准号:
22591108 - 财政年份:2010
- 资助金额:
$ 40万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-canonical functions of the apoptosis inhibitor Bcl-xL
凋亡抑制剂 Bcl-xL 的非典型功能
- 批准号:
8205434 - 财政年份:2010
- 资助金额:
$ 40万 - 项目类别:














{{item.name}}会员




